Author

Reem Hammad

Observed names: Reem Ahmed Hammad, Reem O. Hammad

Institutions: University of Tripoli, Fayoum University

Observed institutions: The University of Texas MD Anderson Cancer Center, Universidad Popular Autónoma del Estado de Puebla, Medical College of Wisconsin, University of Tripoli, Clínica Ruiz, Libyan Academy, Fayoum University

OpenAlex ID: A5114213797

Differential effects of liraglutide naltrexone/bupropion, and caloric restriction on metabolic parameters and beta-cell regeneration in type 2 diabetic rat model: role of beta arrestin 1

2024 · Dina H. Merzeban, Amani M. El Amin Ali, et al. · Journal of Molecular Histology · 3

CML-908: The Impact of Increasing the Dose of Imatinib on the Achievement of Molecular Response in Chronic Myeloid Leukemia Patients: A Retrospective Analysis

2025 · Reem Hammad, Abdul Alfatah Gbaj, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

ALL-701 ALL in Pregnancy With Challenging Conditions & Side Effects

2024 · Reem Hammad, mouna Grain · Clinical Lymphoma Myeloma & Leukemia · 1

POSTER: CML-908 The Impact of Increasing the Dose of Imatinib on the Achievement of Molecular Response in Chronic Myeloid Leukemia Patients: A Retrospective Analysis

2025 · Reem Hammad, Abdul Alfatah Gbaj, et al. · Clinical Lymphoma Myeloma & Leukemia

The Ameliorative Effect of Naltrexone/Bupropion, Liraglutide and Caloric Restriction on Blood Pressure Changes in Diabetic Male Albino Rats

2025 · Reem Ahmed Hammad, Amani M. El Amin, et al. · Fayoum University Medical Journal/Fayoum University Medical Journal

POSTER: CML-415 Comparative Study Between Brand and Generic Imatinib Mesylate Using Molecular Genetic Analysis on CML Libyan Patients

2023 · Reem Hammad, Abdulfatah Gabj · Clinical Lymphoma Myeloma & Leukemia

CML-415 Comparative Study Between Brand and Generic Imatinib Mesylate Using Molecular Genetic Analysis on CML Libyan Patients

2023 · Reem Hammad, Abdulfatah Gabj · Clinical Lymphoma Myeloma & Leukemia

Works count: 7

Citation count: 5

H-index: 1

I10-index: